showed a trendP = 0.11
Complex III (2.5 μM Antimycin A) and pyruvate dehydrogenase‐supported mH 2 O 2 (10 mM pyruvate, 0.5 μM Rotenone to inhibit Complex I) were decreased in the Quad (−53%, P = 0.05) and WG (−60%, P < 0.05), while the diaphragm showed a trend for increased Complex III mH 2 O 2 (+35%, P = 0.11) and no differences in pyruvate dehydrogenase‐supported mH 2 O 2 between D2. mdx and WT (Supporting Information, Figure S4A and S4B ).